Ticker League

Latest period

$0.00

YoY change

5Y CAGR

Peak year (2017)

$1.48M

Dividends Paid history chart for Moderna (MRNA) from 2016 to 2025

Latest: $0.00

Dividends Paid growth chart for Moderna (MRNA) from 2016 to 2025

Latest: -100.0%

Dividends Paid history table for Moderna (MRNA) from 2016 to 2025

  • 2025$0.00
  • 2024$0.00
  • 2023$0.00
  • 2022$0.00
  • 2021$0.00
  • 2020$0.00
  • 2019$0.00
  • 2018$0.00-100.0%
  • 2017$1.48M+134.3%
  • 2016$633.00K

Dividends Paid values are taken from Moderna's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Dividends Paid at Moderna (MRNA)

Dividends Paid for Moderna (MRNA): headline value $0.00. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual dividends paid for Moderna (MRNA) came in at $0.00.

Moderna dividends paid peaked at $1.48M in 2017; the latest annual figure is $0.00 in 2025 (100.0% below peak).

The record annual dividends paid stands at $1.48M, reached in 2017; the historical low of $0.00 was recorded in 2018.

Moderna Dividends Paid by Year

Moderna Dividends Paid 2025: $0.00

Moderna dividends paid in 2025 was $0.00.

Moderna Dividends Paid 2024: $0.00

Moderna dividends paid in 2024 was $0.00.

Moderna Dividends Paid 2023: $0.00

Moderna dividends paid in 2023 was $0.00.

Moderna Dividends Paid 2022: $0.00

Moderna dividends paid in 2022 was $0.00.

Moderna Dividends Paid 2021: $0.00

Moderna dividends paid in 2021 was $0.00.

See more financial history for Moderna (MRNA).

Sector peers by Dividends Paid

Healthcare peers of Moderna (MRNA), ranked by their latest dividends paid

Frequently asked questions

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation